{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T21:25:42Z","timestamp":1765315542645,"version":"3.46.0"},"reference-count":15,"publisher":"BMJ","issue":"6378","license":[{"start":{"date-parts":[[1983,5,21]],"date-time":"1983-05-21T00:00:00Z","timestamp":422323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br Med J (Clin Res Ed)"],"published-print":{"date-parts":[[1983,5,21]]},"DOI":"10.1136\/bmj.286.6378.1625","type":"journal-article","created":{"date-parts":[[2009,4,2]],"date-time":"2009-04-02T11:00:59Z","timestamp":1238670059000},"page":"1625-1628","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin D metabolites and analogues, diphosphonates, danazol, and bromocriptine."],"prefix":"10.1136","volume":"286","author":[{"given":"C R","family":"Paterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Feely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1983,5,21]]},"reference":[{"article-title":"Endocrine properties and clinical application of danazol. Fertil Steril 1979; 31: 237-51. A comprehensive review of the basic pharmacology and the endocrine effects of danazol. The selection of patients and practical application of treatment are discussed","author":"Dmowski, W.P.","key":"ref_1","unstructured":"Dmowski WP. Endocrine properties and clinical application of danazol. Fertil Steril 1979;31:237-51. A comprehensive review of the basic pharmacology and the endocrine effects of danazol. The selection of patients and practical application of treatment are discussed."},{"article-title":"Metabolites and analogues of vitamin D: which for what ? JAMA 1982; 247: 841-4. A brief review of vitamin D metabolism with an outline of the main indications for and drawbacks of each of the metabolites and analogues used in clinical practice","author":"Haussler, M.R.; Cordy, P.E.","key":"ref_2","unstructured":"Haussler MR, Cordy PE. Metabolites and analogues of vitamin D: which for what ?JAMA 1982;247:841-4. A brief review of vitamin D metabolism with an outline of the main indications for and drawbacks of each of the metabolites and analogues used in clinical practice."},{"issue":"5","key":"ref_3","first-page":"\"7","article-title":"Conference proceedings describing clinical studies (many uncontrolled) with danazol in conditions where its efficacy is established (endometriosis, cystic disease of the breast) and where its use is controversial (unexplained infertility, premenstrual syndrome, and precocious puberty). Kanis JA. Osteomalacia and chronic renal failure","volume":"55","author":"Hoffbrand, B.I.; Danazol, Jacobs H.S.","year":"1979","unstructured":"Hoffbrand BI, Jacobs HS. Danazol. Postgrad Med J 1979;55 suppl 5:7-94. Conference proceedings describing clinical studies (many uncontrolled) with danazol in conditions where its efficacy is established (endometriosis, cystic disease of the breast) and where its use is controversial (unexplained infertility, premenstrual syndrome, and precocious puberty). Kanis JA. Osteomalacia and chronic renal failure. J Clin Pathol 1981;34: 1295-307.","journal-title":"Postgrad Med J"},{"key":"ref_4","first-page":"21","volume":"286","author":"MEDICAL, B.R.I.T.I.S.H.","year":"1983","unstructured":"BRITISH MEDICAL JOURNAL VOLUmE 286 21 mAY 1983","journal-title":"JOURNAL"},{"key":"ref_5","first-page":"619","article-title":"Etidronate disodium in the treatment of Paget's disease of bone","volume":"96","author":"Krane, S.M.","year":"1982","unstructured":"Krane SM. Etidronate disodium in the treatment of Paget's disease of bone. Ann Intern Med 1982;96:619-25. A review of the biochemical effects of the diphosphonates and of the clinical trials of different dosage regimens in Paget's disease. A discussion of the relative merits of etidronate disodium and calcitonin is included.","journal-title":"Ann Intern Med; A review of the biochemical effects of the diphosphonates and of the clinical trials of different dosage regimens in Paget's disease. A discussion of the relative merits of etidronate disodium and calcitonin is included"},{"key":"ref_6","first-page":"\"1450","article-title":"No effect of bromocriptine in acromegaly: a controlled trial","volume":"304","author":"1092-3)","year":"1981","unstructured":"Lindholm J, Riishede J, Vestergaard S, Hummer L, Faber 0, Hagen C. No effect of bromocriptine in acromegaly: a controlled trial. N Engl 7 Med 1981;304:1450-4. Doubt cast on the efficacy of bromocriptine. The ensuing correspondence (305:1092-3) puts this study into perspective.","journal-title":"N Engl 7 Med; Doubt cast on the efficacy of bromocriptine"},{"key":"ref_7","first-page":"625","article-title":"A review of the first five years' experience of the use of danazol in the United States. The prospective and comparative controlled trials are outlined as are the investigational uses of danazol in, for example, contraception and systemic lupus erythematosus","volume":"96","author":"Madanes, A.E.; Farber, M.","year":"1982","unstructured":"Madanes AE, Farber M. Danazol. Ann Intern Med 1982;96:625-30. A review of the first five years' experience of the use of danazol in the United States. The prospective and comparative controlled trials are outlined as are the investigational uses of danazol in, for example, contraception and systemic lupus erythematosus.","journal-title":"Danazol. Ann Intern Med"},{"key":"ref_8","first-page":"928","article-title":"Controlled trial of the antigonadotrophin danazol in painful nodular benign breast disease","volume":"i:","author":"Mansel, R.E.; Wisbey, JR, Hughes; L.E.","year":"1982","unstructured":"Mansel RE, Wisbey JR, Hughes LE. Controlled trial of the antigonadotrophin danazol in painful nodular benign breast disease. Lancet 1982; i:928-30. Double blind study reporting objective and subjective improvement and suggesting that 200 mg daily is adequate for most patients.","journal-title":"Lancet; Double blind study reporting objective and subjective improvement and suggesting"},{"key":"ref_9","first-page":"873","article-title":"A review of the pharmacology and therapeutic uses of bromocriptine","volume":"301","author":"Bromocriptine, Parkes D.","year":"1979","unstructured":"Parkes D. Bromocriptine. N EnglJ Med 1979;301:873-8. A review of the pharmacology and therapeutic uses of bromocriptine.","journal-title":"N EnglJ Med"},{"article-title":"Vitamin D poisoning: survey of causes in 21 patients with hypercalcaemia. Lancet 1980; i: 1164-5. An examination of the factors that contributed to episodes of hypercalcaemia in patients taking vitamin D. The cumulative nature of the drug and the importance of regular follow up are emphasised","author":"Paterson, C.R.","key":"ref_10","unstructured":"Paterson CR. Vitamin D poisoning: survey of causes in 21 patients with hypercalcaemia. Lancet 1980;i:1164-5. An examination of the factors that contributed to episodes of hypercalcaemia in patients taking vitamin D. The cumulative nature of the drug and the importance of regular follow up are emphasised."},{"article-title":"Hyperprolactinaemia in men-response to bromocriptine therapy. Lancet 1982; i: 245-8. Recent experience suggesting that bromocriptine may now be the treatment of choice for men with large tumours","author":"Prescott, R.W.G.; Johnston, D.G.; Kendall-Taylor, P.","key":"ref_11","unstructured":"Prescott RWG, Johnston DG, Kendall-Taylor P, et al. Hyperprolactinaemia in men-response to bromocriptine therapy. Lancet 1982;i:245-8. Recent experience suggesting that bromocriptine may now be the treatment of choice for men with large tumours."},{"key":"ref_12","first-page":"271","article-title":"Long-term experience of alphacalcidol in renal osteodystrophy","volume":"51","author":"Sharman, V.L.; Brownjohn, A.M.; Goodwin, F.J.","year":"1982","unstructured":"Sharman VL, Brownjohn AM, Goodwin FJ, et al. Long-term experience of alphacalcidol in renal osteodystrophy. Q J Med 1982;51:271-8. A cautious account of the use of alphacalcidol in 13 patients with renal failure undergoing regular haemodialysis. Hypercalcaemia was common, difficult to prevent, and potentially damaging.","journal-title":"Q J Med; A cautious account of the use of alphacalcidol in 13 patients with renal failure undergoing regular haemodialysis. Hypercalcaemia was common, difficult to prevent, and potentially damaging"},{"article-title":"Pharmacology and therapeutic use of calcitonin. Drugs 1981; 21: 257-72. A review of the physiology and pharmacological use of calcitonin. While its place in the management of Paget's disease is clearly described the other possible indications for its use are also outlined","author":"Stevenson, J.C.; Evans, M.A.","key":"ref_13","unstructured":"Stevenson JC, Evans MA. Pharmacology and therapeutic use of calcitonin. Drugs 1981;21:257-72. A review of the physiology and pharmacological use of calcitonin. While its place in the management of Paget's disease is clearly described the other possible indications for its use are also outlined."},{"article-title":"Penicillinase-producing Neisseria gonorrhoeae in Britain","year":"1982","key":"ref_14","unstructured":"Penicillinase-producing Neisseria gonorrhoeae in Britain 1982"},{"key":"ref_15","unstructured":"The infections regarded as indigenous-that is, when both the patient and consort were infected in Britain-show the greatest increase. The total in this category, 519, is 354 more than in 1981. Of these 519 patients, 154 were stated to have contracted the infection in Greater London and a further 157 were reported from laboratories in that area; Birmingham recorded 30 cases, Liverpool 28, Bristol 20, and Leeds 18, and many other areas had smaller numbers of cases. The shift from importation to endemic transmission of penicillinase-producing Neisseria","article-title":"The infections regarded as indigenous-that is, when both the patient and consort were infected in Britain-show the greatest increase. The total in this category, 519, is 354 more than in 1981. Of these 519 patients, 154 were stated to have contracted the infection in Greater London and a further 157 were reported from laboratories in that area; Birmingham recorded 30 cases, Liverpool 28, Bristol 20, and Leeds 18, and many other areas had smaller numbers of cases. The shift from importation to endemic transmission of penicillinase-producing Neisseria"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.286.6378.1625","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.286.6378.1625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T21:24:36Z","timestamp":1765315476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.286.6378.1625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,5,21]]},"references-count":15,"journal-issue":{"issue":"6378","published-online":{"date-parts":[[1983,5,21]]},"published-print":{"date-parts":[[1983,5,21]]}},"alternative-id":["10.1136\/bmj.286.6378.1625"],"URL":"https:\/\/doi.org\/10.1136\/bmj.286.6378.1625","relation":{},"ISSN":["0007-1447","1468-5833"],"issn-type":[{"type":"print","value":"0007-1447"},{"type":"electronic","value":"1468-5833"}],"subject":[],"published":{"date-parts":[[1983,5,21]]}}}